W. A. Craig
- Pharmacology top 2%
- Molecular Medicine top 1%
- Epidemiology top 10%
- Infectious Diseases top 10%
- Clinical Biochemistry top 2%
- Co-authors
- Steven C. EbertJ. E. LeggettPeter G. WellingB. FantinC. M. KuninAndreas GerberA. Paul VastolaByungse Suh
- Topics
- Antibiotics Pharmacokinetics and Efficacy (10 papers)Antibiotic Resistance in Bacteria (8 papers)Pharmaceutical studies and practices (4 papers)
- Journals
- Clinical Infectious DiseasesThe Journal of Infectious DiseasesAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesCanada
In The Last Decade
W. A. Craig
17 papers receiving 822 citations
Peers
Comparison fields: 5 of 90
- Pharmacology 576
- Molecular Medicine 395
- Epidemiology 273
- Infectious Diseases 213
- Clinical Biochemistry 180
Countries citing papers authored by W. A. Craig
This map shows the geographic impact of W. A. Craig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. A. Craig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. A. Craig more than expected).
Fields of papers citing papers by W. A. Craig
This network shows the impact of papers produced by W. A. Craig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. A. Craig. The network helps show where W. A. Craig may publish in the future.
Co-authorship network of co-authors of W. A. Craig
This figure shows the co-authorship network connecting the top 25 collaborators of W. A. Craig. A scholar is included among the top collaborators of W. A. Craig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. A. Craig. W. A. Craig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 48 | |
| 2 | 151 | |
| 3 | Free drug 24-hr AUC/MIC is the PK/PD target that correlates with in vivo efficacy of macrolides, azalides, ketolides and clindamycin | 21 |
| 4 | Pharmacodynamic activity of BAY 12-8039 in animal infection models | 3 |
| 5 | 192 | |
| 6 | Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models. | 109 |
| 7 | 39 | |
| 8 | 9 | |
| 9 | 25 | |
| 10 | 89 | |
| 11 | 36 | |
| 12 | 31 | |
| 13 | 3 | |
| 14 | Changes in protein binding during disease. | 15 |
| 15 | Theory and practical impact of binding of antimicrobials to serum proteins and tissue. | 33 |
| 16 | 32 | |
| 17 | 58 |
About W. A. Craig
W. A. Craig is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Transplantation, having authored 17 papers that have together received 894 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (8 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Molecular Medicine (395 citations), Pharmacology (576 citations) and Applied Microbiology and Biotechnology (54 citations). W. A. Craig has collaborated with scholars based in United States and Canada. Frequent co-authors include Steven C. Ebert, J. E. Leggett, Peter G. Welling, B. Fantin, C. M. Kunin, Andreas Gerber, A. Paul Vastola, Byungse Suh, William Kirby and Paul G. Ambrose. Their work appears in journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.